サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1402081

過敏性肺炎の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年～2030年、予測

Global Hypersensitivity Pneumonitis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
過敏性肺炎の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年～2030年、予測
出版日: 2023年12月01日
発行: Value Market Research
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

過敏性肺炎市場の世界需要は、調査期間2023年から2030年のCAGRは5.26%で、2022年の9億5,650万米ドルから、2030年までには約14億4,142万米ドルの市場規模に達すると推定されます。

過敏性肺炎（HP）または外因性アレルギー性肺胞炎は、様々な有機物質またはアレルゲンに繰り返し暴露されることによって引き起こされるまれな肺疾患です。感受性のある人がこれらの物質を吸い込むと、免疫系が過剰な免疫反応を起こし、肺に炎症を引き起こします。

市場力学

認知度の向上と診断能力の向上により、過敏性肺炎の症例の特定と報告が容易になり、診断検査と管理戦略の需要が高まっています。カビや鳥の糞などの環境因子とともに、農業や木工などの産業における職業曝露が、この疾患の流行に大きく寄与しています。画像診断技術や肺機能検査などの診断技術の進歩は、過敏性肺炎の正確かつ早期診断に極めて重要な役割を果たしており、診断ツールの需要を促進しています。過敏性肺炎のメカニズムや危険因子の解明に重点を置いた調査は、新たな診断法や治療法の開発につながり、市場をさらに拡大しています。世界のヘルスケア支出の増加により、HP管理のための患者ケアとヘルスケアサービスへのアクセスが向上しています。労働安全衛生と環境衛生に関する政府の政策、規制と政策指針は、過敏性肺炎に対処しやすい環境作りに貢献しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、過敏性肺炎の世界市場における各セグメントを包括的に評価することもできます。過敏性肺炎産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける過敏性肺炎市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 過敏性肺炎-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 過敏性肺炎の世界市場分析：曝露源別

  • 概要：曝露源別
  • 実績データと予測データ
  • 曝露源別分析
  • 職業性曝露
  • 環境アレルゲン
  • 薬剤性曝露
  • その他

第6章 過敏性肺炎の世界市場分析：タイプ別

  • 概要：タイプ別
  • 実績データと予測データ
  • タイプ別分析
  • 慢性過敏性肺炎
  • 急性過敏性肺炎

第7章 世界の過敏性肺炎市場分析：診断別

  • 概要：診断別
  • 実績データと予測データ
  • 診断別分析
  • 肺機能検査
  • 画像検査
  • 生検
  • その他

第8章 過敏性肺炎の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 過敏性肺炎企業の競合情勢

  • 過敏性肺炎市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Johnson & Johnson Services Inc.
  • F.Hoffmann-La Roche Ltd.
  • Boehringer Ingelheim International GmbH
  • AstraZeneca Plc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis International AG
  • Merck KGaA
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Source of Exposure (USD MN)
  • Occupational Exposure Market Sales by Geography (USD MN)
  • Environmental Allergens Market Sales by Geography (USD MN)
  • Drug-Induced Exposure Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Chronic Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
  • Acute Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
  • Analysis by Diagnosis (USD MN)
  • Pulmonary Function Tests Market Sales by Geography (USD MN)
  • Imaging Tests Market Sales by Geography (USD MN)
  • Biopsy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hypersensitivity Pneumonitis Report
  • Market Research Process
  • Market Research Methodology
  • Global Hypersensitivity Pneumonitis Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Source of Exposure
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Diagnosis
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Source of Exposure (USD MN)
  • Occupational Exposure Market Sales by Geography (USD MN)
  • Environmental Allergens Market Sales by Geography (USD MN)
  • Drug-Induced Exposure Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Chronic Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
  • Acute Hypersensitivity Pneumonitis Market Sales by Geography (USD MN)
  • Global Market Analysis by Diagnosis (USD MN)
  • Pulmonary Function Tests Market Sales by Geography (USD MN)
  • Imaging Tests Market Sales by Geography (USD MN)
  • Biopsy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112993

The global demand for Hypersensitivity Pneumonitis Market is presumed to reach the market size of nearly USD 1441.42 MN by 2030 from USD 956.5 MN in 2022 with a CAGR of 5.26% under the study period 2023 - 2030.

Hypersensitivity pneumonitis (HP), or extrinsic allergic alveolitis, is a rare lung condition triggered by repeated exposure to various organic substances or allergens. When susceptible individuals inhale these substances, their immune system mounts an exaggerated immune response, causing inflammation in the lungs.

MARKET DYNAMICS

Increased awareness and improved diagnostic capabilities lead to better identification and reporting of hypersensitivity pneumonitis cases, driving demand for diagnostic tests and management strategies. Occupational exposures in industries like agriculture and woodworking, along with environmental factors such as mold or bird droppings, contribute significantly to the condition's prevalence. Advancements in diagnostic technologies, including imaging techniques and pulmonary function tests, play a pivotal role in accurate and early hypersensitivity pneumonitis diagnosis, fostering demand for diagnostic tools. Research initiatives focusing on understanding HP's mechanisms and risk factors lead to novel diagnostic methods and treatments, further expanding the market. Rising healthcare expenditure globally enables improved patient care and access to healthcare services for HP management. Supportive government policies, regulations, and guidelines pertaining to occupational safety and environmental health contribute to creating an environment conducive to addressing hypersensitivity pneumonitis.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hypersensitivity pneumonitis. The growth and trends of hypersensitivity pneumonitis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the hypersensitivity pneumonitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source Of Exposure

  • Occupational Exposure
  • Environmental Allergens
  • Drug-Induced Exposure
  • Others

By Type

  • Chronic Hypersensitivity Pneumonitis
  • Acute Hypersensitivity Pneumonitis

By Diagnosis

  • Pulmonary Function Tests
  • Imaging Tests
  • Biopsy
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hypersensitivity Pneumonitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hypersensitivity Pneumonitis market include Johnson & Johnson Services Inc., F.Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, AstraZeneca Plc., GlaxoSmithKline plc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Novartis International AG, Merck KGaA, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HYPERSENSITIVITY PNEUMONITIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Source of Exposure
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Diagnosis
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY SOURCE OF EXPOSURE

  • 5.1 Overview by Source of Exposure
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Source of Exposure
  • 5.4 Occupational Exposure Historic and Forecast Sales by Regions
  • 5.5 Environmental Allergens Historic and Forecast Sales by Regions
  • 5.6 Drug-Induced Exposure Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Chronic Hypersensitivity Pneumonitis Historic and Forecast Sales by Regions
  • 6.5 Acute Hypersensitivity Pneumonitis Historic and Forecast Sales by Regions

7 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY DIAGNOSIS

  • 7.1 Overview by Diagnosis
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Diagnosis
  • 7.4 Pulmonary Function Tests Historic and Forecast Sales by Regions
  • 7.5 Imaging Tests Historic and Forecast Sales by Regions
  • 7.6 Biopsy Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HYPERSENSITIVITY PNEUMONITIS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE HYPERSENSITIVITY PNEUMONITIS COMPANIES

  • 9.1. Hypersensitivity Pneumonitis Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF HYPERSENSITIVITY PNEUMONITIS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Johnson & Johnson Services Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. F.Hoffmann-La Roche Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Boehringer Ingelheim International GmbH
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. AstraZeneca Plc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. GlaxoSmithKline plc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Sanofi S.A.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Teva Pharmaceutical Industries Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Novartis International AG
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Merck KGaA
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Others
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies